Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Mouse Models for Diseases in the Cholangiocyte Lineage.

Van Hul N, Lendahl U, Andersson ER.

Methods Mol Biol. 2019;1981:203-236. doi: 10.1007/978-1-4939-9420-5_14.

PMID:
31016657
2.

Evaluation of Sample Preparation Methods for the Analysis of Reef-Building Corals Using ¹H-NMR-Based Metabolomics.

Andersson ER, Day RD, Loewenstein JM, Woodley CM, Schock TB.

Metabolites. 2019 Feb 13;9(2). pii: E32. doi: 10.3390/metabo9020032.

3.

WITHDRAWN: Editorial Introduction.

Bush JO, Andersson ER.

Dev Biol. 2019 Jan 11. pii: S0012-1606(19)30013-2. doi: 10.1016/j.ydbio.2019.01.009. [Epub ahead of print] No abstract available.

PMID:
30639158
4.

Corrigendum to "Cholangiopathies - Towards a molecular understanding" [EBioMedicine 35 (2018) 381-393].

Tam PKH, Yiu RS, Lendahl U, Andersson ER.

EBioMedicine. 2018 Oct;36:564. doi: 10.1016/j.ebiom.2018.09.044. Epub 2018 Oct 9. No abstract available.

5.

Cholangiopathies - Towards a molecular understanding.

Tam PKH, Yiu RS, Lendahl U, Andersson ER.

EBioMedicine. 2018 Sep;35:381-393. doi: 10.1016/j.ebiom.2018.08.024. Epub 2018 Sep 17. Review. Erratum in: EBioMedicine. 2018 Oct;36:564.

6.

Calcium Signaling in Liver Injury and Regeneration.

Oliva-Vilarnau N, Hankeova S, Vorrink SU, Mkrtchian S, Andersson ER, Lauschke VM.

Front Med (Lausanne). 2018 Jul 4;5:192. doi: 10.3389/fmed.2018.00192. eCollection 2018. Review.

7.

Editorial: Signaling pathways instruct the blueprint of life.

Bush JO, Andersson ER.

Dev Biol. 2019 Mar 1;447(1):1-2. doi: 10.1016/j.ydbio.2018.06.002. Epub 2018 Jun 6. No abstract available.

PMID:
29885286
8.

Mouse Model of Alagille Syndrome and Mechanisms of Jagged1 Missense Mutations.

Andersson ER, Chivukula IV, Hankeova S, Sjöqvist M, Tsoi YL, Ramsköld D, Masek J, Elmansuri A, Hoogendoorn A, Vazquez E, Storvall H, Netušilová J, Huch M, Fischler B, Ellis E, Contreras A, Nemeth A, Chien KC, Clevers H, Sandberg R, Bryja V, Lendahl U.

Gastroenterology. 2018 Mar;154(4):1080-1095. doi: 10.1053/j.gastro.2017.11.002. Epub 2017 Nov 21.

9.

Do as I say, Not(ch) as I do: Lateral control of cell fate.

Sjöqvist M, Andersson ER.

Dev Biol. 2019 Mar 1;447(1):58-70. doi: 10.1016/j.ydbio.2017.09.032. Epub 2017 Sep 29. Review.

10.

The developmental biology of genetic Notch disorders.

Mašek J, Andersson ER.

Development. 2017 May 15;144(10):1743-1763. doi: 10.1242/dev.148007. Review.

11.

Therapeutic modulation of Notch signalling--are we there yet?

Andersson ER, Lendahl U.

Nat Rev Drug Discov. 2014 May;13(5):357-78. doi: 10.1038/nrd4252. Review.

PMID:
24781550
12.

Notch signaling maintains neural rosette polarity.

Main H, Radenkovic J, Jin SB, Lendahl U, Andersson ER.

PLoS One. 2013 May 10;8(5):e62959. doi: 10.1371/journal.pone.0062959. Print 2013.

13.

Wnt5a cooperates with canonical Wnts to generate midbrain dopaminergic neurons in vivo and in stem cells.

Andersson ER, Saltó C, Villaescusa JC, Cajanek L, Yang S, Bryjova L, Nagy II, Vainio SJ, Ramirez C, Bryja V, Arenas E.

Proc Natl Acad Sci U S A. 2013 Feb 12;110(7):E602-10. doi: 10.1073/pnas.1208524110. Epub 2013 Jan 16.

14.

Non-canonical Notch signaling activates IL-6/JAK/STAT signaling in breast tumor cells and is controlled by p53 and IKKα/IKKβ.

Jin S, Mutvei AP, Chivukula IV, Andersson ER, Ramsköld D, Sandberg R, Lee KL, Kronqvist P, Mamaeva V, Ostling P, Mpindi JP, Kallioniemi O, Screpanti I, Poellinger L, Sahlgren C, Lendahl U.

Oncogene. 2013 Oct 10;32(41):4892-902. doi: 10.1038/onc.2012.517. Epub 2012 Nov 26.

15.

On how to increase safety innovations.

Andersson ER, Jansson B, Lundblad J.

Int J Inj Contr Saf Promot. 2012;19(3):218-25. doi: 10.1080/17457300.2012.708047. Epub 2012 Jul 30. Review.

PMID:
22839763
16.

SFRP1 and SFRP2 dose-dependently regulate midbrain dopamine neuron development in vivo and in embryonic stem cells.

Kele J, Andersson ER, Villaescusa JC, Cajanek L, Parish CL, Bonilla S, Toledo EM, Bryja V, Rubin JS, Shimono A, Arenas E.

Stem Cells. 2012 May;30(5):865-75. doi: 10.1002/stem.1049.

17.

The role of endocytosis in activating and regulating signal transduction.

Andersson ER.

Cell Mol Life Sci. 2012 Jun;69(11):1755-71. doi: 10.1007/s00018-011-0877-1. Epub 2011 Nov 24. Review.

PMID:
22113372
18.

Notch signaling: simplicity in design, versatility in function.

Andersson ER, Sandberg R, Lendahl U.

Development. 2011 Sep;138(17):3593-612. doi: 10.1242/dev.063610. Review.

19.

Notch induces cyclin-D1-dependent proliferation during a specific temporal window of neural differentiation in ES cells.

Das D, Lanner F, Main H, Andersson ER, Bergmann O, Sahlgren C, Heldring N, Hermanson O, Hansson EM, Lendahl U.

Dev Biol. 2010 Dec 15;348(2):153-66. doi: 10.1016/j.ydbio.2010.09.018. Epub 2010 Sep 29.

20.

Control of Notch-ligand endocytosis by ligand-receptor interaction.

Hansson EM, Lanner F, Das D, Mutvei A, Marklund U, Ericson J, Farnebo F, Stumm G, Stenmark H, Andersson ER, Lendahl U.

J Cell Sci. 2010 Sep 1;123(Pt 17):2931-42. doi: 10.1242/jcs.073239.

21.

Differential involvement of caveolin-1 in brown adipocyte signaling: impaired beta3-adrenergic, but unaffected LPA, PDGF and EGF receptor signaling.

Mattsson CL, Andersson ER, Nedergaard J.

Biochim Biophys Acta. 2010 Aug;1803(8):983-9. doi: 10.1016/j.bbamcr.2010.03.015. Epub 2010 Apr 8.

22.

Delayed dopaminergic neuron differentiation in Lrp6 mutant mice.

Castelo-Branco G, Andersson ER, Minina E, Sousa KM, Ribeiro D, Kokubu C, Imai K, Prakash N, Wurst W, Arenas E.

Dev Dyn. 2010 Jan;239(1):211-21. doi: 10.1002/dvdy.22094.

23.

Genetic interaction between Lrp6 and Wnt5a during mouse development.

Andersson ER, Bryjova L, Biris K, Yamaguchi TP, Arenas E, Bryja V.

Dev Dyn. 2010 Jan;239(1):237-45. doi: 10.1002/dvdy.22101.

24.

Regenerative medicine: a 2009 overview.

Andersson ER, Lendahl U.

J Intern Med. 2009 Oct;266(4):303-10. doi: 10.1111/j.1365-2796.2009.02157.x.

25.

p57Kip2 is a repressor of Mash1 activity and neuronal differentiation in neural stem cells.

Joseph B, Andersson ER, Vlachos P, Södersten E, Liu L, Teixeira AI, Hermanson O.

Cell Death Differ. 2009 Sep;16(9):1256-65. doi: 10.1038/cdd.2009.72. Epub 2009 Jul 10.

26.

Wnt5a is required for endothelial differentiation of embryonic stem cells and vascularization via pathways involving both Wnt/beta-catenin and protein kinase Calpha.

Yang DH, Yoon JY, Lee SH, Bryja V, Andersson ER, Arenas E, Kwon YG, Choi KY.

Circ Res. 2009 Feb 13;104(3):372-9. doi: 10.1161/CIRCRESAHA.108.185405. Epub 2008 Dec 18.

PMID:
19096028
27.

The extracellular domain of Lrp5/6 inhibits noncanonical Wnt signaling in vivo.

Bryja V, Andersson ER, Schambony A, Esner M, Bryjová L, Biris KK, Hall AC, Kraft B, Cajanek L, Yamaguchi TP, Buckingham M, Arenas E.

Mol Biol Cell. 2009 Feb;20(3):924-36. doi: 10.1091/mbc.E08-07-0711. Epub 2008 Dec 3.

28.

Wnt5a regulates ventral midbrain morphogenesis and the development of A9-A10 dopaminergic cells in vivo.

Andersson ER, Prakash N, Cajanek L, Minina E, Bryja V, Bryjova L, Yamaguchi TP, Hall AC, Wurst W, Arenas E.

PLoS One. 2008;3(10):e3517. doi: 10.1371/journal.pone.0003517. Epub 2008 Oct 27.

Supplemental Content

Loading ...
Support Center